Test Price
2,800 AED✅ Home Collection Available
EVC2 Gene (Ellis-van Creveld Syndrome) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين EVC2 (متلازمة إيليس-فان كريفيلد) بالتسلسل الجيني المتقدم في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary — ملخص تنفيذي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity for EVC2 pathogenic variants via ISO Accredited Next‑Generation Sequencing.
- Premium Logistics: Paid Hospital‑Grade Home Collection with ISO Certified Cold‑Chain transport; VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Complimentary telephonic post‑test guidance by a DHA‑licensed geneticist to interpret results and plan next steps.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
فحص جيني متقدم بدقة عالية مع استشارة وراثية معتمدة من هيئة الصحة بدبي.
Test Overview
The EVC2 gene test uses next‑generation sequencing to detect mutations responsible for Ellis‑van Creveld syndrome, a rare skeletal dysplasia with polydactyly and congenital heart defects. اختبار جيني دقيق يقدم تشخيصًا مؤكدًا واستشارة وراثية متكاملة.
| Feature | Our Test (NGS EVC2) | Closest Alternative (Sanger Sequencing Only) |
|---|---|---|
| Precision | Full gene coverage including exon‑intron boundaries, CNV detection | Limited to known point mutations; misses large deletions/duplications |
| Methodology | Next‑Generation Sequencing (NGS), PCR‑free library prep | Capillary Sanger sequencing |
| Turnaround Time | 3 – 4 Weeks (complete clinical report) | 4 – 6 Weeks (excludes reflex testing) |
Physician Insight & Safety Protocol
Clinical Correlation Note from Dr. PRABHAKAR REDDY (DHA: 61713011)
“As a clinical geneticist, I emphasize that a positive result must always be correlated with detailed clinical findings and family history; a negative result does not exclude all genetic etiologies. Continue all prescribed medications and consult your managing physician before making any changes.”
⚠️ Medication Warning: Do not discontinue or adjust any prescribed medication without explicit advice from your treating doctor.
Safety Exclusion Criteria & Emergency Red Flags
- Sample Collection Exclusions: Blood transfusion within the last 2 weeks; active infection or inflammatory condition that may alter DNA yield; inability to provide informed consent (guardian required for minors per CDS Law 2026).
- Test Limitations: Not designed to detect deep intronic variants or mitochondrial disorders; a genetic counselling session is mandatory before testing.
- ER Red Flags: If the patient experiences severe respiratory distress, cyanosis, or acute cardiac symptoms in the context of known Ellis‑van Creveld syndrome, seek emergency medical care immediately.
Frequently Asked Questions
1. What is the EVC2 gene test for?
تحليل تسلسل الجين EVC2 للكشف عن طفرات متلازمة إيليس-فان كريفيلد، وهو مرض وراثي نادر يسبب قصر القامة وكثرة الأصابع وعيوب القلب.
This advanced genetic test identifies pathogenic variants in the EVC2 gene, confirming Ellis‑van Creveld syndrome and enabling accurate genetic counselling and family screening.
2. How is the performed?
يتم جمع عينة دم بسيطة عن طريق خدمة السحب المنزلي المعتمدة، ثم تحليل الحمض النووي بتقنية التسلسل المتقدم.
A DHA‑licensed phlebotomist visits your home for a painless blood draw or FTA card spot collection; the DNA is isolated and sequenced using ISO‑accredited NGS technology.
3. What is the turnaround time and what support is provided?
تتوفر النتائج خلال 3 إلى 4 أسابيع مع تقرير سريري مفصل وجلسة استشارة وراثية هاتفية مجانية.
Results are delivered within 3–4 weeks, accompanied by an interpretive clinical report, and you receive complimentary tele‑counselling to understand findings and hereditary implications.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians